Showing results (171-180 of 247) with videos related to
Sort By:
Pageof 25
Therapie|March 7, 2002
[Hepatotoxicity of a synthetic cortisol antagonist: OP'DDD (mitotane)]O Neuman, E Bruckert, R Chadarevian, et al.Thrombosis Research|December 10, 1999
Relationship between triglycerides and factor VIIc and plasminogen activator inhibitor type-1: lack of threshold valueR Chadarevian, E Bruckert, S Dejager, et al.Human Mutation|January 1, 1996
Phenotypic expression in double heterozygotes for familial hypercholesterolemia and familial defective apolipoprotein B-100P Benlian, J L de Gennes, F Dairou, et al.Metabolism: Clinical and Experimental|April 1, 1994
Evidence of non-deficient low-density lipoprotein receptor patients in a pool of subjects with clinical familial hypercholesterolemia profileS Lestavel-Delattre, S Benhamamouch, G Agnani, et al.La Nouvelle Presse Medicale|June 27, 1981
[Inappropriate thyrotropin secretion. Part 2: non tumoral (author's transl)]P Hamon, J L Baulieu, R Doumith, et al.Pathologie-Biologie|April 1, 1997
[Relationship between iron status and diet in 410 hyperlipidemic patients]C Marchand, E Bruckert, N Jacob, et al.Journal of Pediatric Surgery|July 21, 2026
Neonatal outcomes following open versus minimally invasive surgery for duodenal atresia: A propensity score matched analysisPaulo Castro, Alexa G Turpin, Lindsey Asti, et al.Atherosclerosis|September 16, 1999
Cysteine is a cardiovascular risk factor in hyperlipidemic patientsN Jacob, E Bruckert, P Giral, et al.La Nouvelle Presse Medicale|June 20, 1981
[Inappropriate thyrotropin secretion. Part 1: tumoral (author's transl)]P Hamon, J L Baulieu, R Doumith, et al.Presse Medicale (Paris, France : 1983)|September 17, 1994
[Endocrine diseases in POEMS syndrome. Apropos of 4 cases]A P Gimenez-Roqueplo, S Casanova, E Bruckert, et al.Pageof 25